Characterization of differential gene expression in adrenocortical tumors harboring β-catenin (CTNNB1) mutations

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages

  Durand, Julien ^a   Lampron, Antoine ^a   Mazzuco, Tania L ^a   Chapman, Audrey ^a   Bourdeau, Isabelle ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL PROTEIN; ISTHMIN 1; MESSENGER RNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE 2A; PHYTANOYL COENZYME A 2 HYDROXYLASE INTERACTING PROTEIN; PKF 115 584; PNU 74654; PROTEIN ENC1; PROTEIN INHIBITOR; RALA BINDING PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL GLAND; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CELL NUCLEUS; CLINICAL ARTICLE; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; WILD TYPE;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; BETA CATENIN; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MUTATION; WNT PROTEINS;

EID: 79960091259     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2143     Document Type: Article

References (20)

1. Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher- Lavenu MC, Perret C, Bertherat J 2005 Mutations of β-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65:7622-7627 (Pubitemid 41297234)
2. Tadjine M, Lampron A, Ouadi L, Bourdeau I 2008 Frequent mutations of β-catenin gene in sporadic secreting adrenocortical adenomas. Clin Endocrinol (Oxf) 68:264-270
3. Masi G, Lavezzo E, Iacobone M, Favia G, Palù G, Barzon L 2009 Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors. J Endocrinol Invest 32:597-600
4. Moon RT, Kohn AD, De Ferrari GV, Kaykas A 2004 WNT and β-catenin signalling: diseases and therapies. Nat Rev Genet 5:691-701 (Pubitemid 39150127)
5. Doghman M, Cazareth J, Lalli E 2008 The T cell factor/β-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells. J Clin Endocrinol Metab 93:3222-3225
6. Berthon A, Sahut-Barnola I, Lambert-Langlais S, de Joussineau C, Damon-Soubeyrand C, Louiset E, Taketo MM, Tissier F, Bertherat J, Lefrançois-Martinez AM, Martinez A, Val P 2010 Constitutive β-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum Mol Genet 19:1561-1576
7. Tetsu O, McCormick F 1999 β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426 (Pubitemid 29180374)
8. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
9. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F 2002 Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172-1183 (Pubitemid 34094853)
10. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW 1998 Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512 (Pubitemid 28425575)
11. Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M 2006 Target genes of the WNT/β-catenin pathway in Wilms tumors. Genes Chromosomes Cancer 45:565-574 (Pubitemid 43727163)
12. Schwartz DR, Wu R, Kardia SL, Levin AM, Huang CC, Shedden KA, Kuick R, Misek DE, Hanash SM, Taylor JM, Reed H, Hendrix N, Zhai Y, Fearon ER, Cho KR 2003 Novel candidate targets of β-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 63: 2913-2922 (Pubitemid 36667164)
13. Weidinger G, Thorpe CJ, Wuennenberg-Stapleton K, Ngai J, Moon RT 2005 The Sp1-related transcription factors sp5 and sp5-like act downstream of Wnt/β-catenin signaling in mesoderm and neuroectoderm patterning. Curr Biol 15:489-500 (Pubitemid 40413387)
14. Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS 2010 RLIP76: a versatile transporter and an emerging target for cancer therapy. Biochem Pharmacol 79:1699-1705
15. Rosman GJ, Martins TJ, Sonnenburg WK, Beavo JA, Ferguson K, Loughney K 1997 Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase. Gene 191:89-95 (Pubitemid 27254410)
16. Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y 2001 Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the β-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res 61:7722-7726 (Pubitemid 33049355)
17. Provost E, Yamamoto Y, Lizardi I, Stern J, D'Aquila TG, Gaynor RB, Rimm DL 2003 Functional correlates of mutations in β-catenin exon 3 phosphorylation sites. J Biol Chem 278:31781-31789 (Pubitemid 37048359)
18. Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G, Hammer G 2009 Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 15:668-676
19. Bonnet S, Gaujoux S, Launay P, Baudry C, Chokri I, Ragazzon B, Libé R, René-Corail F, Audebourg A, Vacher-Lavenu MC, Groussin L, Bertagna X, Dousset B, Bertherat J, Tissier F 2011 Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J Clin Endocrinol Metab 96:E419-E426
20. Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA 2010 Small molecule inhibitors of Wnt/β-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia 12:326-35